Atlas Trials

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Clinical trial NCT01280266 · COMPLETED

Trial details

NCT number
NCT01280266
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Raynaud Phenomenon
Start date
2011-01-01
Primary completion
2011-05-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.